Surmodics | SRDX - Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
Align Technology USD 0 0 2024-12
Arrowhead Research USD 538.1M 323.22M 2025-12
Artivion USD 217.81M 2.94M 2025-12
Baxter International USD 9.47B 726M 2025-12
Boston Scientific USD 10.99B 12M 2025-09
EDAP TMS EUR 1.01M 13K 2025-09
Edwards Lifesciences USD 598.2M 200K 2025-09
Haemonetics USD 919.99M 406K 2025-12
Heron Therapeutics USD 140.64M 975K 2025-12
J&J USD 39.44B 30M 2025-12
Merit Medical Systems USD 734.04M 1.12M 2025-12
Mesa Laboratories USD 104.2M 104.3M 2024-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Option Care Health USD 1.15B 1M 2025-12
Stryker USD 14.86B 14M 2025-12
Surmodics USD 29.55M 30K 2024-09
Trinity Biotech USD 114.86M 4.81M 2025-09